Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,340 | -48,486 | -163,458 | -118,986 | -71,971 |
| Depreciation Amortization | 3,565 | 1,789 | 2,995 | 2,294 | 1,446 |
| Accounts payable and accrued liabilities | 3,084 | 905 | -1,037 | 3,184 | -4,741 |
| Other Working Capital | -2,774 | -1,864 | 10,444 | 6,412 | -1,286 |
| Other Operating Activity | 13,898 | 7,641 | 40,612 | 25,637 | 23,841 |
| Operating Cash Flow | $-68,567 | $-40,015 | $-110,444 | $-81,459 | $-52,711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 84,037 | -10,001 | -319,133 | -259,231 | -176,899 |
| PPE Investments | -3,946 | -2,851 | -40,657 | -27,381 | -17,415 |
| Sale Of Investment | N/A | 105,000 | 227,155 | 143,275 | 54,174 |
| Investing Cash Flow | $80,091 | $92,148 | $-132,635 | $-143,337 | $-140,140 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | N/A | 25,000 | 25,000 | 25,000 |
| Common Stock Issued | 742 | 486 | 2,413 | 1,843 | 1,371 |
| Common Stock Repurchased | N/A | N/A | -122 | -122 | N/A |
| Financing Cash Flow | $25,742 | $486 | $27,291 | $26,721 | $26,371 |
| Beginning Cash Position | 93,633 | 93,633 | 309,421 | 309,421 | 309,421 |
| End Cash Position | 130,899 | 146,252 | 93,633 | 111,346 | 142,941 |
| Net Cash Flow | $37,266 | $52,619 | $-215,788 | $-198,075 | $-166,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,567 | -40,015 | -110,444 | -81,459 | -52,711 |
| Capital Expenditure | -3,946 | -2,851 | -40,657 | -27,381 | -17,415 |
| Free Cash Flow | -72,513 | -42,866 | -151,101 | -108,840 | -70,126 |